Erez Chimovits
CIK 1706399 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.59M
Companies
6
Total Filings
20
Lifetime Open-Market Net
$29.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UPB | Director | 973,716 | $6.40 | $6.23M | $14.03M | 4 | 2026-06-11 |
| BiomX Inc. (PHGE.U) Delisted | 10%+ Owner | 13,797,997 | $0.90 | $12.42M | -$37.1K | 2 | 2024-05-20 |
| ACET | Director | 43,128 | $8.20 | $353.6K | $0 | 2 | 2021-02-18 |
| LogicBio Therapeutics, Inc. (LOGC) Delisted | Director | 4,126,972 | $7.06 | $29.14M | $13.79M | 5 | 2020-10-05 |
| BiomX Inc. (PHGE.WS) Delisted | Director | 2,313,489 | $0.01 | $20.4K | $199.2K | 4 | 2020-03-27 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Director | 3,183,314 | — | — | $2.00M | 3 | 2020-02-25 |
Recent Filings · Page 2 of 2
20 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-27 | BiomX Inc. (PHGE.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-25 | Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Sell (S) | — | $0 | EDGAR |
| 2019-12-20 | LogicBio Therapeutics, Inc. (LOGC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-20 | BiomX Inc. (PHGE.WS) Delisted | Buy (P) | +4,000 | $35.6K | EDGAR |
| 2019-12-12 | BiomX Inc. (PHGE.WS) Delisted | Buy (P) | +8,800 | $77.9K | EDGAR |
| 2019-12-09 | BiomX Inc. (PHGE.WS) Delisted | Buy (P) | +10,200 | $85.6K | EDGAR |
| 2019-07-15 | Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-06 | Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Buy (P) | +646,204 | $2.00M | EDGAR |
| 2018-10-25 | LogicBio Therapeutics, Inc. (LOGC) Delisted | Mixed | +3,487,760 | $4.90M | EDGAR |
| 2018-10-22 | LogicBio Therapeutics, Inc. (LOGC) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.